This article was originally published in The Gray Sheet
EnteroMedics appoints president and CEO; former Medtronic chair elected to Halyard Health Board of Directors; T2 Biosystems names chief commercial officer; AngioDynamics CFO transition; new Merit Medical Systems CFO tapped.
You may also be interested in...
Medtech veteran Bill Hawkins is the new board chair of 4Tech, a startup developing transcatheter tricuspid valve repair devices.
Ivenix names Stuart Randle CEO, as IsoRay Chairman and CEO Dwight Babcock retires; EnteroMedics' new CEO Dan W. Gladney restructures head office; Sunshine Heart names new clinical affairs chief; and more personnel news from around the industry.
The agency approved EnteroMedics’ Maestro neuromodulator to treat obesity despite the device not meeting endpoints in its pivotal trial. The agency relied in part on a survey that found obese patients willing to take more risks in exchange for weight loss.